Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

How Early Data Drives Better Cell Line Performance
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest phases of cell line development. read more
Should Sponsors Provide Source Document Templates?
Sponsor-provided templates provide a compelling opportunity to improve upstream trial execution. However, in today’s world of increasingly complex and data-driven trials, the opportunity comes with important caveats. read more
Post-Approval Change Management
Achieving global approval for a single change may take three to five years, but inefficient lifecycle change management rarely registers as a crisis. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Harbour BioMed, Sinopharm Form R&D Consortium for Innovative Biologics
Wednesday, July 29, 2026
Harbour BioMed and China National Pharmaceutical Group announced a strategic collaboration to establish a joint innovation R&D consortium focused on ... read more
AsymBio Breaks Ground on Fengxian R&D Building to Expand Biologics Services
Wednesday, July 29, 2026
AsymBio has begun construction of a new R&D building at its Shanghai Fengxian site, a move the company said will strengthen its biologics CDMO ... read more
ICON, Anthropic Launch Multi-Year AI Collaboration for Clinical Trials
Tuesday, July 28, 2026
ICON has announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle, expanding the ... read more
Novogene Europe Expands Single-Cell Sequencing Capability at Cambridge Omics Centre
Monday, July 27, 2026
Novogene Europe announced that it has expanded its single-cell RNA sequencing capability at its Cambridge Omics Centre. This expansion brings single-... read more
Pace Life Sciences Announces Compliant FDA Inspection of Operations in Research Triangle Park, NC
Monday, July 27, 2026
Pace® Life Sciences announced the successful completion of an FDA inspection of its Small Molecule Center of Excellence in Research Triangle Park, ... read more